Compare · AAON vs TMO
AAON vs TMO
Side-by-side comparison of AAON Inc. (AAON) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AAON and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $177.93B, about 23.3x AAON ($7.64B).
- Over the past year, AAON is down 3.4% and TMO is up 14.2% - TMO leads by 17.6 points.
- AAON has been more active in the news (17 items in the past 4 weeks vs 9 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 11 for AAON).
- Company
- AAON Inc.
- Thermo Fisher Scientific Inc
- Price
- $93.33+7.90%
- $479.36+2.79%
- Market cap
- $7.64B
- $177.93B
- 1M return
- +12.79%
- -2.51%
- 1Y return
- -3.40%
- +14.23%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 17
- 9
- Recent ratings
- 11
- 25
AAON Inc.
AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada. It offers rooftop units, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, self-contained units, coils, and controls. The company markets and sells its products to retail, manufacturing, educational, lodging, supermarket, medical, and other commercial industries. It sells its products through a network of manufacturers' representatives and internal sales force. The company was incorporated in 1987 and is based in Tulsa, Oklahoma.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest AAON
- New insider Cheung Chung Kin claimed ownership of 2,034 shares (SEC Form 3)
- Amendment: Chief Accounting Officer Thompson Rebecca sold $729,929 worth of shares (7,292 units at $100.10) as part of a pre-agreed trading plan and exercised 7,292 shares at a strike of $29.48, increasing direct ownership by 36% to 27,681 units (SEC Form 4)
- Amendment: Chief Accounting Officer Thompson Rebecca exercised 21,914 shares at a strike of $29.48 and sold $2,196,002 worth of shares (21,914 units at $100.21) as part of a pre-agreed trading plan, increasing direct ownership by 380% to 27,681 units (SEC Form 4)
- Amendment: Chief Accounting Officer Thompson Rebecca exercised 2,287 shares at a strike of $29.48 and sold $228,952 worth of shares (2,287 units at $100.11) as part of a pre-agreed trading plan, increasing direct ownership by 9% to 27,681 units (SEC Form 4)
- Chief Accounting Officer Thompson Rebecca exercised 400 shares at a strike of $29.48 and sold $40,108 worth of shares (400 units at $100.27) (SEC Form 4)
- Amendment: New insider Bomer Luke A. claimed ownership of 747 shares (SEC Form 3)
- Chief Accounting Officer Thompson Rebecca exercised 21,914 shares at a strike of $29.48 and sold $2,196,002 worth of shares (21,914 units at $100.21) (SEC Form 4)
- SEC Form 144 filed by AAON Inc.
- Chief Accounting Officer Thompson Rebecca exercised 7,292 shares at a strike of $29.48 and sold $729,929 worth of shares (7,292 units at $100.10) (SEC Form 4)
- AAON Announces First Quarter 2026 Conference Call and Webcast
Latest TMO
- President & COO Pettiti Gianluca sold $185,064 worth of shares (400 units at $462.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,051 units (SEC Form 4)
- Thermo Fisher Scientific to Host Investor Day
- Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026